Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.
Goy A, Kalayoglu Besisik S, Drach J, Ramchandren R, Robertson MJ, Avivi I, Rowe JM, Herbrecht R, Van Hoof A, Zhang L, Cicero S, Fu T, Witzig T. Goy A, et al. Among authors: kalayoglu besisik s. Br J Haematol. 2015 Aug;170(4):496-503. doi: 10.1111/bjh.13456. Epub 2015 Apr 28. Br J Haematol. 2015. PMID: 25921098 Free PMC article. Clinical Trial.
Criteria for Hyperinflammation Developing in COVID-19: Analysis of 2 Cohorts From Different Periods of the Pandemic.
Amikishiyev S, Gunver MG, Bektas M, Aghamuradov S, Ince B, Koca N, Torun ES, Aliyeva N, Sari S, Cetin C, Yalcin-Dulundu BC, Deniz R, Kemik F, Agargun BF, Gulseren UA, Besisik B, Alkan O, Bagriacik C, Tor YB, Senkal N, Catma Y, Durak G, Mese S, Agacfidan A, Kose M, Erelel M, Cagatay AA, Simsek-Yavuz S, Kalayoglu-Besisik S, Esen F, Gül A. Amikishiyev S, et al. Among authors: kalayoglu besisik s. Arthritis Rheumatol. 2023 May;75(5):664-672. doi: 10.1002/art.42417. Epub 2023 Mar 20. Arthritis Rheumatol. 2023. PMID: 36508470 Free PMC article.
Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.
Goy A, Sinha R, Williams ME, Kalayoglu Besisik S, Drach J, Ramchandren R, Zhang L, Cicero S, Fu T, Witzig TE. Goy A, et al. Among authors: kalayoglu besisik s. J Clin Oncol. 2013 Oct 10;31(29):3688-95. doi: 10.1200/JCO.2013.49.2835. Epub 2013 Sep 3. J Clin Oncol. 2013. PMID: 24002500 Free PMC article. Clinical Trial.
Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.
Witzig TE, Luigi Zinzani P, Habermann TM, Tuscano JM, Drach J, Ramchandren R, Kalayoglu Besisik S, Takeshita K, Casadebaig Bravo ML, Zhang L, Fu T, Goy A. Witzig TE, et al. Among authors: kalayoglu besisik s. Am J Hematol. 2017 Oct;92(10):E575-E583. doi: 10.1002/ajh.24854. Epub 2017 Aug 28. Am J Hematol. 2017. PMID: 28699256 Free PMC article. Clinical Trial.
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience.
Özbalak M, Güzel Mastanzade M, Özlük Ö, Tiryaki TO, Erdem S, Özbalak EP, Elverdi T, Yönal Hindilerden İ, Altay AY, Yeğen G, Eşkazan AE, Ar MC, Yenerel MN, Soysal T, Nalçacı M, Ferhanoğlu B, Kalayoğlu Beşışık S. Özbalak M, et al. Among authors: kalayoglu besisik s. Turk J Haematol. 2022 Dec 1;39(4):254-261. doi: 10.4274/tjh.galenos.2022.2022.0142. Epub 2022 Jun 3. Turk J Haematol. 2022. PMID: 35657203 Free PMC article.
Prolonged Severe Watery Diarrhea in a Long-Term Myeloma Survivor: An Unforeseen Infection with Cystoisospora belli.
Tiryaki TO, Anıl KU, Büyük M, Yıldırım AY, Atasoy A, Çiftçibaşı Örmeci A, Kalayoğlu Beşışık S. Tiryaki TO, et al. Among authors: kalayoglu besisik s. Turk J Haematol. 2021 Jun 1;38(2):171-173. doi: 10.4274/tjh.galenos.2020.2020.0414. Epub 2020 Oct 28. Turk J Haematol. 2021. PMID: 33112100 Free PMC article. No abstract available.
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.
Akay OM, Ozbalak M, Pehlivan M, Yildiz B, Uzay A, Yigenoglu TN, Elverdi T, Kaynar L, Ayyildiz O, Yonal Hindilerden I, Goksoy HS, Izmir Guner S, Gunes AK, Sonmez M, Kurt Yuksel M, Civriz Bozdag S, Ozkurt ZN, Toptas T, Dogu MH, Salim O, Saydam G, Yavasoglu I, Ayli M, Ozet G, Albayrak M, Birtas Atesoglu E, Toprak SK, Yildirim R, Mehtap O, Kalayoglu Besisik S, Nalcaci M, Altuntas F, Ferhanoglu B. Akay OM, et al. Among authors: kalayoglu besisik s. Hematol Oncol. 2021 Oct;39(4):498-505. doi: 10.1002/hon.2897. Epub 2021 Jun 25. Hematol Oncol. 2021. PMID: 34171130
60 results